Âé¶¹´«Ã½

    Advertisement
    The Tribune, California19:54
    Swansea University13:26
    Zacks18:52
    The Business Standard08:02
    pharmaphorum06:39
    IDLProcycling11:38
    In the last 2 hours
    The Motley Fool01:14
    In the last 8 hours
    The Tribune, California19:54 12-Jun-25
    Yesterday
    Zacks18:52 12-Jun-25
    Scrip Pharma Intelligence17:34 12-Jun-25
    Swansea University13:26 12-Jun-25
    Benzinga13:19 12-Jun-25
    Novo Nordisk13:14 12-Jun-25
    IDLProcycling11:38 12-Jun-25
    IDLProcycling11:28 12-Jun-25
    The Business Standard08:02 12-Jun-25
    Pharmaceutical Technology07:31 12-Jun-25
    pharmaphorum06:39 12-Jun-25
    In the last 7 days
    Seeking Alpha17:34 11-Jun-25
    BioWorld17:00 11-Jun-25
    Scrip Pharma Intelligence16:48 11-Jun-25
    Quartz13:41 11-Jun-25
    TipRanks12:05 11-Jun-25
    Benzinga11:14 11-Jun-25
    Zacks11:08 11-Jun-25
    LADbible10:22 11-Jun-25
    Yahoo! UK & Ireland09:04 11-Jun-25
    The Harvard Law School Forum on Corporate Governance07:42 11-Jun-25
    Chemical & Engineering News07:24 11-Jun-25
    Forbes07:06 11-Jun-25
    PR Newswire (Press Release)07:02 11-Jun-25
    Pharmacy Times17:05 10-Jun-25
    TipRanks14:52 10-Jun-25
    Yahoo! US11:24 10-Jun-25
    Yahoo! UK & Ireland11:11 10-Jun-25
    Novo Nordisk08:23 10-Jun-25
    PR Newswire (Press Release)08:05 10-Jun-25
    ProMarket.org06:41 10-Jun-25
    Proactive Investors (US)04:33 10-Jun-25
    HedgeWeek04:19 10-Jun-25
    The Motley Fool03:34 10-Jun-25
    The Motley Fool18:56 9-Jun-25
    Yahoo! UK & Ireland14:10 9-Jun-25
    Reuters13:47 9-Jun-25
    The Irish Times13:39 9-Jun-25
    Zacks12:58 9-Jun-25
    Reuters12:16 9-Jun-25
    pharmaphorum07:07 9-Jun-25
    The Motley Fool18:52 8-Jun-25
    SAMAA02:08 7-Jun-25
    Blavity19:52 6-Jun-25
    Zacks15:23 6-Jun-25
    Zacks13:40 6-Jun-25
    The Seattle Times12:38 6-Jun-25
    TipRanks10:20 6-Jun-25
    Benzinga10:15 6-Jun-25
    Zacks10:06 6-Jun-25
    News & Observer, North Carolina09:32 6-Jun-25
    PR Newswire (Press Release)09:15 6-Jun-25
    Clinical Services Journal06:52 6-Jun-25
    PR Newswire (Press Release)06:15 6-Jun-25
    The Motley Fool04:44 6-Jun-25
    In the last month
    STAT09:06 5-Jun-25
    pharmaphorum07:54 5-Jun-25
    LADbible05:08 5-Jun-25
    STAT04:32 5-Jun-25
    The Motley Fool04:22 5-Jun-25
    Santa Fe New Mexican22:30 4-Jun-25
    Santa Fe New Mexican20:48 4-Jun-25
    Law36019:36 4-Jun-25
    NPR14:15 4-Jun-25
    FiercePharma12:39 4-Jun-25
    PharmaTimes06:26 4-Jun-25
    The Motley Fool06:19 4-Jun-25
    Bloomberg Law05:44 4-Jun-25
    The Week (India)12:26 3-Jun-25
    UNILAD11:25 3-Jun-25
    PR Newswire (Press Release)10:08 3-Jun-25
    Zacks12:48 2-Jun-25
    Benzinga12:20 2-Jun-25
    Bangkok Post06:30 2-Jun-25
    The Hindu Business Line05:51 2-Jun-25
    South China Morning Post22:38 1-Jun-25
    Barchart08:06 1-Jun-25
    The Hindu12:26 31-May-25
    The Hindu Business Line11:06 31-May-25
    The Business Standard05:59 31-May-25
    The Irish Times02:11 31-May-25
    The Times of India20:05 30-May-25
    The Motley Fool08:06 30-May-25
    The Motley Fool07:04 30-May-25
    Quartz05:07 30-May-25
    EurActiv.com00:00 30-May-25
    Seeking Alpha18:28 29-May-25
    The Business Standard06:40 29-May-25
    Investors Chronicle05:35 29-May-25
    Law36020:32 28-May-25
    ENDPOINTS13:54 28-May-25
    The Harvard Law School Forum on Corporate Governance09:36 28-May-25
    Bangkok Post05:36 28-May-25
    The Motley Fool04:23 28-May-25
    Above the Law16:47 27-May-25
    Zacks13:41 27-May-25
    Proactive Investors (UK)12:07 27-May-25
    The Motley Fool10:45 27-May-25
    Business Wire (Press Release)09:36 27-May-25
    PR Newswire (Press Release)07:07 27-May-25
    Zacks10:12 26-May-25
    Forbes08:03 26-May-25
    Seeking Alpha01:36 26-May-25
    The Irish Times01:17 26-May-25
    The Seattle Times23:27 25-May-25
    Futurism07:13 25-May-25
    Health Magazine15:06 23-May-25
    Automation.com13:26 23-May-25
    Zacks12:18 23-May-25
    Benzinga11:28 23-May-25
    Zacks09:25 23-May-25
    i News07:26 23-May-25
    Boston Globe19:18 22-May-25
    Korea JoongAng Daily18:04 22-May-25
    view more headlines
    13 Jun 01:14

    About our Novo Nordisk news

    Latest news on Novo Nordisk, a global healthcare company focused on diabetes care, obesity treatment, and other serious chronic diseases. Get updates on Novo Nordisk's products, research, financial performance, and stock price.

    Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, the company has grown to become a global leader in diabetes care, with a strong presence in the fields of hemophilia, growth hormone therapy, and obesity treatment. Novo Nordisk's key products include insulin analogs like Tresiba and Levemir, GLP-1 receptor agonists such as Victoza and Ozempic, and obesity drugs like Saxenda and Wegovy.

    Stay informed about the latest developments in Novo Nordisk's research and development pipeline, including updates on clinical trials, regulatory approvals, and new product launches. Our feed covers the company's ongoing efforts to innovate and improve treatments for diabetes, obesity, and other metabolic disorders, such as the development of oral semaglutide and the exploration of novel drug targets.

    In addition to product news, our Novo Nordisk feed keeps you updated on the company's financial performance, including quarterly earnings reports, sales figures, and market share data. We also cover key events and announcements that may impact Novo Nordisk's stock price (NYSE: NVO), such as strategic partnerships, acquisitions, and leadership changes.

    Beyond the business aspects, our feed highlights Novo Nordisk's commitment to corporate social responsibility and sustainability. From initiatives to improve access to diabetes care in developing countries to efforts to reduce the company's environmental footprint, we provide a comprehensive view of Novo Nordisk's impact on global health and society.

    As the prevalence of diabetes and obesity continues to rise worldwide, Novo Nordisk plays a crucial role in addressing these global health challenges. Our Âé¶¹´«Ã½ feed on Novo Nordisk brings you the most relevant and up-to-date information from reliable sources, helping you stay informed about this innovative and influential healthcare company.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.